Skip to main content
Psychiatry
ALL Specialities
ALL Specialities
/
Psychiatry
COVID-19 Updates
News
From the Journals
FDA/CDC
Guidelines
Feature
Latest News
News by Conference
News from the FDA/CDC
Perspectives
Commentary
Curbside Consult
Families in Psychiatry
For Residents
From the Editor
Interview
Mental Health Consult
Shrink Rap News
Techiatry
Weighty Issues
Supplements
Reviews
Cases That Test Your Skills
Clinical Neuroscience
Evidence-Based Reviews
Med/Psych Update
Out of the Pipeline
Pearls
Savvy Psychopharmacology
CME
CME Supplements
Medical Education Library
Diseases and Conditions
Addiction Medicine
ADHD
Alzheimer's & Cognition
Anxiety Disorders
Bipolar Disorder
Depression
Eating Disorders
Movement Disorders
Personality Disorders
PTSD
Schizophrenia & Other Psychotic Disorders
Sleep Medicine
Somatic Disorders
Multimedia
Podcasts
Video
Resource Center
Lifestyle
Conference Coverage
Benzodiazepines and antidepressants do not impair cognition in midlife schizophrenia
Publish date:
September 27, 2017
AT THE ECNP CONGRESS
bjancin@frontlinemedcom.com
Pages
« first
1
2
Recommended Reading
Paranoia and suicidality after starting treatment for lupus
MDedge Psychiatry
For first-episode psychosis, psychiatrists should behave like cardiologists
MDedge Psychiatry
VIDEO: What role does autoimmune dysfunction play in schizophrenia?
MDedge Psychiatry
Can melatonin alleviate antipsychotic-induced weight gain?
MDedge Psychiatry
Suspicious, sleepless, and smoking
MDedge Psychiatry
Austedo approved for treatment of tardive dyskinesia
MDedge Psychiatry
Ethics in compulsory treatment of patients with severe mental illness
MDedge Psychiatry
A call for psychiatrists with clozapine expertise in schizophrenia
MDedge Psychiatry
Palliative care for patients suffering from severe persistent mental illness
MDedge Psychiatry
Antipsychotics may reduce mortality in schizophrenia
MDedge Psychiatry
Schizophrenia & Other Psychotic Disorders
Depression
All Specialties